{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:50:56Z","timestamp":1781913056607,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["heartrhythmcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HeartRhythm Case Reports"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.hrcr.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:25:54Z","timestamp":1561681554000},"page":"497-500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immune checkpoint inhibitor\u2013mediated myocarditis and ventricular tachycardia storm"],"prefix":"10.1016","volume":"5","author":[{"given":"Lachlan M.","family":"McDowall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suran L.","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhita","family":"Ange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin K.M.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrcr.2019.06.006_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40425-016-0152-y","article-title":"Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy","volume":"4","author":"Heinzerling","year":"2016","journal-title":"J Immunotherapy Cancer"},{"key":"10.1016\/j.hrcr.2019.06.006_bib2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrcr.2019.06.006_bib3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hrcr.2019.06.006_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/L17-0396","article-title":"Survival after fulminant myocarditis induced by immune-checkpoint inhibitors","volume":"167","author":"Arangalage","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrcr.2019.06.006_bib5","first-page":"92.e1","article-title":"Immune checkpoint inhibitor-associated myocarditis: a new challenge for cardiologists","volume":"34","author":"Frigeri","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hrcr.2019.06.006_bib6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrcr.2019.06.006_bib7","doi-asserted-by":"crossref","first-page":"1657310","DOI":"10.1155\/2017\/1657310","article-title":"Esophageal cancer metastases to unexpected sites: a systematic review","volume":"2017","author":"Shaheen","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.hrcr.2019.06.006_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hrcr.2019.06.006_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.hrcr.2019.06.006_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.hrcr.2019.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216228","article-title":"Suspected autoimmune myocarditis and cardiac conduction abnormalities with nivolumab therapy for non-small cell lung cancer","volume":"2016","author":"Gibson","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.hrcr.2019.06.006_bib12","doi-asserted-by":"crossref","first-page":"692A","DOI":"10.1016\/j.chest.2017.08.720","article-title":"Fatal myocarditis: a rare but life threatening adverse effect of nivolumab chemotherapy","volume":"152","author":"Hassam","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.hrcr.2019.06.006_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/bjc.2017.253","article-title":"Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy","volume":"117","author":"Tay","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hrcr.2019.06.006_bib14","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.18632\/oncotarget.22579","article-title":"Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer","volume":"8","author":"Brustle","year":"2017","journal-title":"Oncotarget"}],"container-title":["HeartRhythm Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214027119300740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214027119300740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:32:07Z","timestamp":1761993127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214027119300740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2214027119300740"],"URL":"https:\/\/doi.org\/10.1016\/j.hrcr.2019.06.006","relation":{},"ISSN":["2214-0271"],"issn-type":[{"value":"2214-0271","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitor\u2013mediated myocarditis and ventricular tachycardia storm","name":"articletitle","label":"Article Title"},{"value":"HeartRhythm Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrcr.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}